BridgeBio Oncology Therapeutics, Inc. (BBOT) total assets for Q2 2026 were $417.65M, a decrease of -6.85% from the previous quarter. BBOT total liabilities were $45.37M for the fiscal quarter, a 21.67 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results